GlassScriptPhysician profile
Ignatius D Roger
NPI 1699832667
$600.97
in general payments reported to CMS, 2019-2025
9 companies · $50.64 in 2025
The $50.64 reported for 2025 was less than what a typical Surgery of The Hand (Plastic Surgery) provider received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $91.86 · 2020: $79.80 · 2021: $24.15 · 2022: $184 · 2023: $113 · 2024: $57.69 · 2025: $50.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $220.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $209.14 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Djo, LLC | $112.50 | 2023 | Cmf |
| Endo Pharmaceuticals INC. | $84.94 | 2019-2022 | |
| Pacira Therapeutics, INC. | $55.65 | 2019 | |
| Stryker Corporation | $50.64 | 2025 | Gamma |
| Axogen | $33.25 | 2020 | |
| Zyla Life Sciences, INC. | $24.74 | 2020 | |
| Anika Therapeutics, INC. | $15.81 | 2019 | |
| Acumed LLC | $14.30 | 2024 | Acumed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ignatius Roger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.